EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs

Karolina Wojtowicz, Michał Nowicki

Biochemical and Biophysical Research Communications · 2023-06 · 662 · 1-7

DOI: 10.1016/j.bbrc.2023.04.059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-06. Verfasst von Karolina Wojtowicz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: kwojtowicz@ump.edu.pl. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The cancer-associated fibroblasts (CAFs) are one of the most abundant components of the tumor microenvironment (TME). CAFs have been implicated in tumor progression, extracellular matrix (ECM) remodeling, and treatment resistance. Drug resistance is the primary limiting factor in achieving cures for patients with cancer, particularly ovarian cancer. Therefore, inhibiting CAFs can be an effective strategies for cancer treatment. In this research, we studied whether CAFs have an influence on drug-sensitive ovarian cancer cells to become more resistant. We examined the influence of CAFs on genes and proteins expression changes in sensitive ovarian cancer cells. We prepared a 3D co-culture to investigate the role of CAFs on cancer cell morphology. METHODS: Here, we performed a detailed analysis of drug-sensitive ovarian cancer cell lines (A2780 and W1) and the influence of ovarian CAFs on the A2780 and W1 cells morphology, genes and proteins expression. The 2D and 3D cultures, genes expression analysis (TaqMan qPCR), and proteins expression (Western blot analysis) were assessed in this study. RESULTS: We observed upregulation of ABCC5, CYP2C8, CYP2C9, and DHFR mRNA in cell lines supplemented by CAFs medium. We showed fibronectin overexpression and COL3A1 downregulation after supplementation with CAFs. Co-culturing with CAFs prevented the formation of spheroids in 3D conditions. CONCLUSION: We demonstrated that the process of drug resistance in ovarian cancer cells is launched by CAFs. CAFs not only simulate cancer cells to produce drug transporters and specific enzymes production, but also remodel the TME to increase drug resistance. We believe that cancer progression and migration is due to the CAFs po-tumorigenic activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsCancer-Associated FibroblastsHumansFemaleCell Line, TumorCoculture TechniquesTumor Microenvironment

Stichwörter der Autor:innen

CAFsCancer associated fibroblastDrug resistanceOvarian cancer cell lines

Autor:innen und Institutionen

  • Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland. Electronic address: kwojtowicz@ump.edu.pl.
  • Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland.

Förderung

  • Narodowe Centrum Nauki

Zitieren

APA

Wojtowicz, K., & Nowicki, M. (2023). The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs. Biochemical and Biophysical Research Communications, 662, 1-7. https://doi.org/10.1016/j.bbrc.2023.04.059

Vancouver

Wojtowicz K, Nowicki M. The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs. Biochemical and Biophysical Research Communications. 2023;662:1-7. doi:10.1016/j.bbrc.2023.04.059

BibTeX
@article{Wojtowicz2023,
  author = {Wojtowicz, Karolina and Nowicki, Michał},
  title = {The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2023},
  volume = {662},
  pages = {1--7},
  doi = {10.1016/j.bbrc.2023.04.059}
}
Kostenlos starten →